Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Christoph Dehnert"'
Autor:
William K. Cornwell, Aaron L. Baggish, Yadav Kumar Deo Bhatta, Maria Joan Brosnan, Christoph Dehnert, J. Sawalla Guseh, Debra Hammer, Benjamin D. Levine, Gianfranco Parati, Eugene E. Wolfel
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 19 (2021)
An increasing number of individuals travel to mountainous environments for work and pleasure. However, oxygen availability declines at altitude, and hypoxic environments place unique stressors on the cardiovascular system. These stressors may be exac
Externí odkaz:
https://doaj.org/article/0e4ebc6d846747a8933aaabd75d87a24
Autor:
Matthias Peter Hilty, Stefanie Zügel, Michele Schoeb, Katja Auinger, Christoph Dehnert, Marco Maggiorini
Publikováno v:
Mediators of Inflammation, Vol 2018 (2018)
Externí odkaz:
https://doaj.org/article/b8918905e3e84bac94c7937b359d198d
Autor:
Heimo Mairbäurl, Christoph Dehnert, Franziska Macholz, Daniel Dankl, Mahdi Sareban, Marc M. Berger
Publikováno v:
International Journal of Molecular Sciences, Vol 20, Iss 17, p 4105 (2019)
Individuals ascending rapidly to altitudes >2500 m may develop symptoms of acute mountain sickness (AMS) within a few hours of arrival and/or high-altitude pulmonary edema (HAPE), which occurs typically during the first three days after reaching alti
Externí odkaz:
https://doaj.org/article/a830a401959c44b99a57ca80b7b3a736
Autor:
Matthias Peter Hilty, Stefanie Zügel, Michele Schoeb, Katja Auinger, Christoph Dehnert, Marco Maggiorini
Publikováno v:
Mediators of Inflammation, Vol 2016 (2016)
Introduction. Acute exposure to high altitude induces inflammation. However, the relationship between inflammation and high altitude related illness such as high altitude pulmonary edema (HAPE) and acute mountain sickness (AMS) is poorly understood.
Externí odkaz:
https://doaj.org/article/d0e864fb24994890b1bcafcacb71eabc
Autor:
Christoph Dehnert
Publikováno v:
Aktuelle Kardiologie. 9:146-152
ZusammenfassungEine Sporttauglichkeitsuntersuchung zur Identifikation von Krankheiten oder Risikofaktoren, die sich durch Sport verschlechtern oder dauerhafte Schäden bzw. einen plötzlichen Herztod verursachen können, ist bei allen sporttreibenden
Autor:
Debra Hammer, Yadav Kumar Deo Bhatta, Benjamin D. Levine, Eugene E. Wolfel, Christoph Dehnert, Gianfranco Parati, Aaron L. Baggish, Maria Joan Brosnan, William K. Cornwell, Vascular Biology, J. Sawalla Guseh
Publikováno v:
Journal of the American Heart Association. 10
An increasing number of individuals travel to mountainous environments for work and pleasure. However, oxygen availability declines at altitude, and hypoxic environments place unique stressors on the cardiovascular system. These stressors may be exac
Autor:
Christine Fischer, Kai Schommer, Katrin Hinderhofer, Nicola Benjamin, Marc M. Berger, Ekkehard Grünig, Heimo Mairbäurl, Peter Bärtsch, Christina A. Eichstaedt, Jie Song, Christoph Dehnert
Publikováno v:
High altitude medicinebiology. 21(1)
Background: Exaggerated pulmonary arterial hypertension (PAH) is a hallmark of high-altitude pulmonary edema (HAPE). The objective of this study was therefore to investigate genetic predisposition ...
Autor:
Peter Bärtsch, Christoph Dehnert
Publikováno v:
Flugmedizin · Tropenmedizin · Reisemedizin - FTR. 25:69-74
ZusammenfassungAbsolute Höhe, Vorakklimatisation, Aufstiegsgeschwindigkeit und individuelle Anfälligkeit sind die wichtigsten Prädiktoren der akuten Bergkrankheit (ABK), des Höhenhirnödems (HHÖ) und des Höhenlungenödems (HLÖ). Die Anfälligk
Autor:
Christoph Dehnert, Peter Bärtsch
Publikováno v:
Primary and hospital care: médecine interne générale. 18:45-50
Autor:
Marc M. Berger, Daniel Dankl, Mahdi Sareban, Heimo Mairbäurl, Franziska Macholz, Christoph Dehnert
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 20, Iss 17, p 4105 (2019)
International Journal of Molecular Sciences, Vol 20, Iss 17, p 4105 (2019)
Individuals ascending rapidly to altitudes >2500 m may develop symptoms of acute mountain sickness (AMS) within a few hours of arrival and/or high-altitude pulmonary edema (HAPE), which occurs typically during the first three days after reaching alti